635 related articles for article (PubMed ID: 19237093)
21. First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Koivisto TT; Rautelin HI; Voutilainen ME; Heikkinen MT; Koskenpato JP; Färkkilä MA
Aliment Pharmacol Ther; 2005 Mar; 21(6):773-82. PubMed ID: 15771764
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
[TBL] [Abstract][Full Text] [Related]
23. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
24. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
25. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
26. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
28. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
29. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
30. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.
Uygun A; Kadayifci A; Yesilova Z; Ates Y; Safali M; Ilgan S; Bagci S; Dagalp K
Indian J Gastroenterol; 2007; 26(4):174-7. PubMed ID: 17986746
[TBL] [Abstract][Full Text] [Related]
31. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication.
Danese S; Armuzzi A; Romano A; Cremonini F; Candelli M; Franceschi F; Ojetti V; Venuti A; Pola P; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2001; 48(38):465-7. PubMed ID: 11379334
[TBL] [Abstract][Full Text] [Related]
33. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Thong-Ngam D; Mahachai V
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
[TBL] [Abstract][Full Text] [Related]
34. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
Cammarota G; Martino A; Pirozzi G; Cianci R; Branca G; Nista EC; Cazzato A; Cannizzaro O; Miele L; Grieco A; Gasbarrini A; Gasbarrini G
Aliment Pharmacol Ther; 2004 Apr; 19(7):789-95. PubMed ID: 15043520
[TBL] [Abstract][Full Text] [Related]
35. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
[TBL] [Abstract][Full Text] [Related]
36. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter pylori eradication therapy with bismuth citrate/amoxycillin combination therapy].
Stanescu A; Mayer D; Gabard B; Jost G; Baczako K; Dragici A; Malfertheiner P
Leber Magen Darm; 1996 Jan; 26(1):32-6. PubMed ID: 8851875
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
39. First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
Gisbert JP; Fernández-Bermejo M; Molina-Infante J; Pérez-Gallardo B; Prieto-Bermejo AB; Mateos-Rodríguez JM; Robledo-Andrés P; González-García G
Aliment Pharmacol Ther; 2007 Aug; 26(3):495-500. PubMed ID: 17635384
[TBL] [Abstract][Full Text] [Related]
40. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.
Ciccaglione AF; Cellini L; Grossi L; Manzoli L; Marzio L
Helicobacter; 2015 Oct; 20(5):390-6. PubMed ID: 25801708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
